Profiel
Kathleen Wilkinson is currently the Director at North Texas Commission and the Chief People Officer at Rapport Therapeutics, Inc. Formerly, Ms. Wilkinson was the Chief People Officer at 2seventy Bio, Inc. from 2022 to 2024, the Chief People Officer at bluebird bio, Inc. in 2021, and the Operations Director at Adnexus.
Ms. Wilkinson completed undergraduate studies at Harvard University.
Actieve functies van Kathleen Wilkinson
| Bedrijven | Functie | Begin |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Human Resources Officer | 01-02-2024 |
North Texas Commission
North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kathleen Wilkinson
| Bedrijven | Functie | Einde |
|---|---|---|
| 2SEVENTY BIO, INC. | Human Resources Officer | 01-02-2024 |
| GENETIX BIOTHERAPEUTICS, INC. | Human Resources Officer | 01-12-2021 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Operationeel Directeur | - |
Opleiding van Kathleen Wilkinson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
North Texas Commission
North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Commercial Services |
2seventy Bio, Inc.
2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
















